Abstract

Myxoinflammatory fibroblastic sarcoma is a rare low grade malignant soft tissue tumor, mainly affecting middle-aged persons, and located in the distal extremities. The absence of clinical and radiological signs specific to this tumor makes it confused with many benign lesions and leads to inappropriate treatment. Though it is classified as a low grade tumor, it is reported to have an important infiltrative character responsible for a considerable rate of local recurrence. The therapeutic management of this tumor remains a subject of debate, there are no formal standard treatment protocols. In this presentation, we aimed to report the case of a patient with myxoinflammatory fibroblastic sarcoma of the foot treated successfully by surgery with adjuvant radiotherapy.

Keywords: Acral Myxoinflammatory Fibroblastic Sarcoma (AMIFS); Radiotherapy; Foot

References

1. Meis-Kindblom JM., et al. “Acral myxoinflammatory fibroblastic sarcoma: a low-grade tumor of the hands and feet”. The American Journal of Surgical Pathology 22 (1998): 911.
2. Montgomery EA., et al. “Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin’s disease, and various sarcomas”. Modern Pathology 11 (1998): 384.
3. M Miettinen., et al. “Inflammatory myxohyaline tumor od distal extremities (acral myxoinflammatory fibroblastic sarcoma)”. In Tumors of the Soft Tissues, S. G. Silverberg, Edition (2014): 190-192.
4. JM Meis., et al. “Myxoinflammtory fibroblastic sarcoma”. In WHO Classification of Tumours of Soft Tissue and Bone, C. D. M. Fletcher, J. A. Bridge, P. C. W. Hogendoorn, and F. Mertens, Editions (2013): 87-88.
5. Chahdi H., et al. “Acral myxoinflammatory fibroblastic sarcoma”. Orthopaedics and Traumatology: Surgery and Research 96 (2010): 597-599.
6. E Ieremia and K Thway. “Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates”. Archives of Pathology and Laboratory Medicine 138.10 (2014): 1406-1411.
7. CR Antonescu., et al. “Consistent t (1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor”. Genes, Chromosomes and Cancer 50.10 (2011): 757-764.
8. A Mansoor., et al. “Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments”. Cancer Genetics and Cytogenetics 152.1 (2004): 61-65.
9. AG Silver., et al. “Acral myxoinflammatory fibroblastic sarcoma: A case report and literature review”. Canadian Journal of Plastic Surgery 21.2 (2013): 92-94.
10. Lang J E., et al. “Case reports: acral myxoinflammatory fibroblastic sarcoma: a report of five cases and literature review”. Clinical Orthopaedics and Related Research 445 (2006): 254-260.
11. Lombardi R., et al. “A case of lung metastasis in myxoinflammatory fibroblastic sarcoma: analytical review of one hundred and thirty-eight cases”. International Orthopaedics 37 (2013): 2429-2436.
12. Baldini EH., et al. “Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk”. Journal of Clinical Oncology 17 (1999): 3252-3259.
13. Tejwani A., et al. “Management of acral myxoinflammatory fibroblastic sarcoma”. Cancer 116 (2010): 5733-5739.
14. Hassanein A., et al. “Acral myxoinflammatory fibroblastic sarcomas: Are they all low-grade neoplasms?” Journal of Cutaneous Pathology 35 (2008): 186-191.

Citation

Citation: Khaled Khelil., et al. “Acral Myxoinflammatory Fibroblastic Sarcoma of the Foot: A Case Report". Acta Scientific Medical Sciences 4.9 (2020): 97-101.

Copyright

Copyright: © 2020 Khaled Khelil., et al This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.